EKF Diagnostics Investor Announcements

EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.

2nd Jun 2016

EKF Diagnostics Holdings plc announces the successful completion of the Placing announced this morning.

2nd Jun 2016
2nd Jun 2016

EKF Diagnostics Holdings plc announces the proposed placing of up to 42,205,707 new ordinary shares of 1 penny each in the Company by way of an accelerated book build (the “Placing”).

2nd Jun 2016

Christopher Mills, EKF’s Non-Executive Chairman, will make a statement at the Company’s Annual General Meeting to be held at 11.00am today.  

9th May 2016
26th Apr 2016
22nd Apr 2016


  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

Mount Sinai investments related

RNS announcements